We recently reported that VM formation in gallbladder cancers through the activation of a key VM-related signaling pathway—the EphA2/FAK/Paxillin signaling pathway in the 3-D matrices of highly aggressive GBC-SD cells in vitro and GBC-SD nude mouse xenografts in vivo[42]. The gene discussed is PTK2; the disease is gallbladder cancer.